PedAM
Pediatric Disease Annotations & Medicines
| Disease | pneumonia |
| Symptom | C0024299|lymphoma |
| Sentences | 10 |
| PubMedID- 24428909 | Of the other two, one was already on chemotherapy treatment for lymphoma and died due to uncontrollable atypical pneumonia while the other had an advanced cardiovascular disease and died due to congestive heart failure. |
| PubMedID- 25715489 | Aim: to assess the results of diagnosing and treating pneumocystis pneumonia (pp) in patients with hodgkin lymphoma (hl) over 15 years. |
| PubMedID- 21192884 | L. pneumophila with mixed flora was identified in a perirectal abscess (8) and in skin samples from a patient with lymphoma and cellulitis associated with pneumonia (9). |
| PubMedID- 25909634 | Prophylaxis and treatment of pneumocystis jiroveci pneumonia in lymphoma patients subjected to rituximab-contained therapy: a systemic review and meta-analysis. |
| PubMedID- 26587361 | On clinical suspicion of malignant lymphoma (ml) complicated with pneumonia, we performed a video-assisted thoracoscopic lymph node biopsy while continuing administration of β-lactam antibiotics (tazobactam/piperacillin: taz/pipc 13.5 g/day). |
| PubMedID- 23991330 | Pneumocystis jiroveci pneumonia in patients with non-hodgkin's lymphoma after rituximab-containing regimen: two cases of report and literature review. |
| PubMedID- 23053189 | Point prevalence of pneumocystis pneumonia in patients with non-hodgkin lymphoma according to the number of cycles of r-chop chemotherapy. |
| PubMedID- 21123974 | Two cases of pneumocystis jiroveci pneumonia with non-hodgkin's lymphoma after chop-based chemotherapy containing rituximab. |
| PubMedID- 21575318 | There was secondary hlh owing to systemic onset juvenile idiopathic arthritis in two patients, and one each had anaplastic large cell lymphoma, measles with pneumonia, disseminated tuberculosis, dengue hemorrhagic fever and lymphoproliferative disorder. |
| PubMedID- 20919860 | An increasing incidence of pneumocystis jiroveci pneumonia (pcp) in patients with b-cell non-hodgkin lymphoma (b-nhl) receiving rituximab treatment has been reported. |
Page: 1